These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 22892904

  • 1. Microvascular cerebral blood volume changes in aging APP(swe)/PS1(dE9) AD mouse model: a voxel-wise approach.
    Zerbi V, Jansen D, Dederen PJ, Veltien A, Hamans B, Liu Y, Heerschap A, Kiliaan AJ.
    Brain Struct Funct; 2013 Sep; 218(5):1085-98. PubMed ID: 22892904
    [Abstract] [Full Text] [Related]

  • 2. DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice.
    Hooijmans CR, Van der Zee CE, Dederen PJ, Brouwer KM, Reijmer YD, van Groen T, Broersen LM, Lütjohann D, Heerschap A, Kiliaan AJ.
    Neurobiol Dis; 2009 Mar; 33(3):482-98. PubMed ID: 19130883
    [Abstract] [Full Text] [Related]

  • 3. Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice.
    Hooijmans CR, Graven C, Dederen PJ, Tanila H, van Groen T, Kiliaan AJ.
    Brain Res; 2007 Nov 21; 1181():93-103. PubMed ID: 17916337
    [Abstract] [Full Text] [Related]

  • 4. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C, Miao J, Li Z.
    Behav Brain Res; 2011 Sep 23; 222(2):342-50. PubMed ID: 21513747
    [Abstract] [Full Text] [Related]

  • 5. Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease.
    Do TM, Alata W, Dodacki A, Traversy MT, Chacun H, Pradier L, Scherrmann JM, Farinotti R, Calon F, Bourasset F.
    Neuropharmacology; 2014 Jun 23; 81():311-7. PubMed ID: 24631967
    [Abstract] [Full Text] [Related]

  • 6. Reduction of hippocampal N-acetyl aspartate level in aged APP(Swe)/PS1(dE9) transgenic mice is associated with degeneration of CA3 pyramidal neurons.
    Xu W, Zhan Y, Huang W, Wang X, Zhang S, Lei H.
    J Neurosci Res; 2010 Nov 01; 88(14):3155-60. PubMed ID: 20806406
    [Abstract] [Full Text] [Related]

  • 7. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
    Kuznetsova E, Schliebs R.
    Curr Pharm Des; 2013 Nov 01; 19(38):6749-65. PubMed ID: 23530514
    [Abstract] [Full Text] [Related]

  • 8. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S, Counts SE, Ma SY, Dadko E, Gordon MN, Morgan D, Mufson EJ.
    Exp Neurol; 2001 Aug 01; 170(2):227-43. PubMed ID: 11476589
    [Abstract] [Full Text] [Related]

  • 9. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T, Kiliaan AJ, Kadish I.
    Neurobiol Dis; 2006 Sep 01; 23(3):653-62. PubMed ID: 16829076
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
    Kandimalla KK, Wengenack TM, Curran GL, Gilles EJ, Poduslo JF.
    J Pharmacol Exp Ther; 2007 Aug 01; 322(2):541-9. PubMed ID: 17505020
    [Abstract] [Full Text] [Related]

  • 11. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice.
    Laursen B, Mørk A, Plath N, Kristiansen U, Bastlund JF.
    Behav Brain Res; 2013 Mar 01; 240():146-52. PubMed ID: 23178660
    [Abstract] [Full Text] [Related]

  • 12. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD).
    Hooijmans CR, Rutters F, Dederen PJ, Gambarota G, Veltien A, van Groen T, Broersen LM, Lütjohann D, Heerschap A, Tanila H, Kiliaan AJ.
    Neurobiol Dis; 2007 Oct 01; 28(1):16-29. PubMed ID: 17720508
    [Abstract] [Full Text] [Related]

  • 13. Sensorimotor gating and memory deficits in an APP/PS1 double transgenic mouse model of Alzheimer's disease.
    Wang H, He J, Zhang R, Zhu S, Wang J, Kong L, Tan Q, Li XM.
    Behav Brain Res; 2012 Jul 15; 233(1):237-43. PubMed ID: 22595040
    [Abstract] [Full Text] [Related]

  • 14. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.
    Van Dorpe J, Smeijers L, Dewachter I, Nuyens D, Spittaels K, Van Den Haute C, Mercken M, Moechars D, Laenen I, Kuiperi C, Bruynseels K, Tesseur I, Loos R, Vanderstichele H, Checler F, Sciot R, Van Leuven F.
    Am J Pathol; 2000 Oct 15; 157(4):1283-98. PubMed ID: 11021833
    [Abstract] [Full Text] [Related]

  • 15. Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes.
    Howlett DR, Richardson JC, Austin A, Parsons AA, Bate ST, Davies DC, Gonzalez MI.
    Brain Res; 2004 Aug 13; 1017(1-2):130-6. PubMed ID: 15261108
    [Abstract] [Full Text] [Related]

  • 16. Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    O'Leary TP, Brown RE.
    Behav Brain Res; 2009 Jul 19; 201(1):120-7. PubMed ID: 19428625
    [Abstract] [Full Text] [Related]

  • 17. Restoration of cerebral and systemic microvascular architecture in APP/PS1 transgenic mice following treatment with Liraglutide™.
    Kelly P, McClean PL, Ackermann M, Konerding MA, Hölscher C, Mitchell CA.
    Microcirculation; 2015 Feb 19; 22(2):133-45. PubMed ID: 25556713
    [Abstract] [Full Text] [Related]

  • 18. The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease.
    Hamilton A, Holscher C.
    Brain Res; 2012 Apr 17; 1449():83-93. PubMed ID: 22418058
    [Abstract] [Full Text] [Related]

  • 19. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
    Browne TC, McQuillan K, McManus RM, O'Reilly JA, Mills KH, Lynch MA.
    J Immunol; 2013 Mar 01; 190(5):2241-51. PubMed ID: 23365075
    [Abstract] [Full Text] [Related]

  • 20. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
    He J, Luo H, Yan B, Yu Y, Wang H, Wei Z, Zhang Y, Xu H, Tempier A, Li X, Li XM.
    Neurobiol Aging; 2009 Aug 01; 30(8):1205-16. PubMed ID: 18079026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.